Our previous study found that EA treatment promoted VEGF angiogenesis in a model of myocardial ischemia by increasing H3K9ace occupation of the VEGF promoter region, thus upregulating VEGF expression [27]. The gene discussed is VEGFA; the disease is myocardial ischemia.